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Introduction {#sec1}
============

*PBRM1*, a gene that encodes a subunit of the PBRM1-Brg1/Brm-associated factors (PBAF) chromatin remodeling complex, is mutated in over 3% of all cancers with the highest mutation rate occurring in clear cell renal cell carcinoma (ccRCC), where it is mutated in 40%--50% of patients ([@bib5], [@bib48], [@bib64]). The PBAF chromatin remodeling complex is a minor subcomplex of the human SWI/SNF, or BAF, chromatin remodeling family, subunits of which (*SMARCA4* \[BRG1\], *ARID1A*, and *SMARCB1* \[SNF5 or BAF47\]) are also frequently mutated in cancers ([@bib32], [@bib56]). Along with PBRM1, the PBAF subcomplex exclusively contains ARID2, BRD7, BAF45A, as well as several subunits shared with the more abundant BAF complex ([@bib33], [@bib62], [@bib69]). PBRM1 is composed of several domains associated with binding to chromatin including six tandem bromodomains (BDs), two bromo-adjacent homology domains, and a high-mobility group, implicating PBRM1 as a chromatin-targeting subunit of PBAF. For the most part, the chromatin signatures bound by PBRM1 have not yet been determined, although histone 3 lysine 14 acetylation (H3K14Ac) has been defined as a primary target for the second bromodomain (BD2) *in vitro* ([@bib6]), and validated as the acetylation mark most critical for association of the full PBAF complex to histone peptides ([@bib50]). PBRM1 has homology to RSC1, RSC2, and RSC4 subunits of the yeast RSC chromatin remodeling complex, which also interacts with H3K14Ac, particularly during DNA damage ([@bib14], [@bib66]). However, unlike subunits of RSC, PBRM1 does not seem to be necessary for viability in the majority of mammalian cell types, and in fact, although PBRM1 is essential for embryonic heart development in mice ([@bib26], [@bib65]), adult mice with knockout of PBRM1 are phenotypically normal except for an age-related hematopoietic stem cell defect ([@bib40]).

The most well-defined cellular role for PBRM1 is in DNA damage repair ([@bib4], [@bib34]), which is in line with observation of H3K14Ac at sites of DNA damage ([@bib39]); however, the low mutational burden and relative genome stability of PBRM1-mutant tumors makes it unclear how this role in DNA damage repair relates to the tumor-suppressive phenotypes of PBRM1 ([@bib54]). As such, most of the focus has been on deciphering how transcriptional functions for PBRM1 relate to a role in tumor suppression. Transcriptional profiling of human ccRCC indicates that PBRM1 mutant tumors have a hypoxic transcriptional signature ([@bib54]), which is in agreement with recent reports that mutation of PBRM1 amplifies the hypoxia-inducible factor (HIF) transcriptional program signature induced upon von Hippel-Lindau (VHL) deletion in cell culture ([@bib17]) and in a mouse renal cancer model ([@bib46]). Recent work with kidney-specific (KSP and PAX8) Cre mouse models indicates that VHL knockout or PBRM1 knockout alone is not sufficient for cancer formation but that both are required for kidney tumor formation in mice ([@bib15], [@bib23], [@bib46]).

Although these recent mouse studies have solidified a role for PBRM1 as a bona fide tumor suppressor in renal cancer, the molecular mechanism by which PBRM1 acts as a tumor suppressor is still unclear. For example, PBRM1 exhibits tumor-suppressive phenotypes in a subset of cancer cell lines ([@bib10], [@bib27], [@bib68]), but PBRM1 knockdown in many cell lines produces no phenotype ([@bib10], [@bib17]) or even decreases cellular viability ([@bib40]). In the renal cancer setting, this context-specific function is mediated, in part, through HIF1a expression, which is required for PBRM1\'s tumor suppressor phenotype in renal cell lines ([@bib45]) ([@bib57]); however, the context-dependent function observed in other cell types is still undefined. Here we used epithelial cell lines to define how the function of PBRM1 in non-transformed cells may relate to its function as a tumor suppressor. Through genome-wide transcriptional analysis, we have defined a general role for PBRM1 in regulating the expression of genes involved in stress response, particularly endoplasmic reticulum (ER) stress and apoptosis. To support this general function, we have found that loss of PBRM1 results in accumulation of reactive oxygen species (ROS) and a failure to induce apoptosis under a variety of high-stress conditions. Based on our findings, we propose that PBRM1 acts to regulate stress response genes that restrain cellular proliferation under low-stress conditions but protect cells under high-stress conditions.

Results {#sec2}
=======

Knockdown of PBRM1 in Epithelial Cells Promotes Growth and a Loss of Epithelial Cell Maintenance {#sec2.1}
------------------------------------------------------------------------------------------------

As mutation of PBRM1 in epithelial cells is an early event in tumorigenesis ([@bib19]) we set out to understand the tumor-suppressive role PBRM1 plays in various cell models of epithelium. We depleted *PBRM1* using lentiviral short hairpin RNA (shRNA) in several epithelial cell lines including the immortalized human kidney epithelial cell line HK-2, the canine kidney epithelial cell line MDCK, and the mouse mammary epithelial cell line NMuMG ([Figure S1](#mmc1){ref-type="supplementary-material"}A). In addition to its role in renal cancer, PBRM1 acts as a tumor suppressor in mammary-epithelium-derived cancers as observed in PBRM1-mutated ([@bib68]) and PBRM1-downregulated breast cancers ([Figure S1](#mmc1){ref-type="supplementary-material"}B) ([@bib44]). The loss of PBRM1 resulted in an increase in proliferation in all of these cell lines ([Figure 1](#fig1){ref-type="fig"}A). As NMuMG is the most commonly used cell model of epithelial differentiation, we used it for further analysis and validated the PBRM1 knockdown phenotype using CRISPR-mediated knockout of PBRM1 ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}C). In NMuMG cells, knockdown of PBRM1 decreases protein levels of E-cadherin, a marker of epithelial cells, and increases vimentin, a marker of mesenchymal cells ([Figure 1](#fig1){ref-type="fig"}B) ([@bib35]). A decrease in E-cadherin at adherens junctions results in a weakening of cell-cell adhesion and also results in the release of bound β-catenin, which normally anchors E-cadherin to the actin cytoskeleton ([@bib35]). In agreement with this, we observed an increase in nuclear β-catenin signaling upon PBRM1 knockdown ([Figure 1](#fig1){ref-type="fig"}C). The complete loss of E-cadherin expression and cellular morphology characteristic of a robust epithelial-to-mesenchymal transition (EMT) was not observed; instead, the observed phenotypes reflect a partial EMT or a reduction in epithelial maintenance. The same phenotypes were also observed upon knockdown of BRD7, another PBAF-specific subunit ([@bib33]), although these findings are complicated by a decrease in PBRM1 upon BRD7 knockdown ([Figure S1](#mmc1){ref-type="supplementary-material"}D). Consistent with the documented role for the BAF complex in maintaining human mammary epithelial proliferation ([@bib11]), knockdown of BAF subunits ARID1A or BRG1 resulted in cell arrest and death (data not shown).Figure 1Knockdown of PBRM1 in Cell Line Models of Epithelial Differentiation Promotes Growth and a Loss of Epithelial Cell Maintenance(A) Epithelial cell lines HK-2 (human kidney), MDCK (canine kidney), and NMuMG (mouse mammary), were counted after 72 h growth, and cell number are presented as mean ± SD. n = 3--5.(B) Immunoblot analysis of whole-cell lysates from NMuMG cells indicates that PBRM1 knockdown results in decreased E-cadherin and increased vimentin expression. Quantification represented as percent of shPBRM1 over vector.(C) β-Catenin signaling, as measured using TopFlash reporter assay in NMuMG cells with vector control or shPBRM1. Individual replicates are presented as mean ± SD, n = 8.(D) Migration differences determined by measuring the cell-free area at 40× magnification at 0 and 8 h after scratching with standard pipette tip. The data from 12 independent images were statistically analyzed and presented as mean ± SD, n = 12.(E) Acini with hollow lumen from NMuMG cells grown in 3D culture for 10 days were counted in a blinded manner, and the frequency was calculated from total acini in a field of image (average of 5--6 acini per field). The data from 11 independent images were statistically analyzed (Student\'s t test) and presented as mean ± SD, n = 11. Representative image of acini grown for 14 days were analyzed using immunofluorescence staining with anti-ZO1 (red) and anti-alpha-6-integrin (green). Nuclei (blue) were visualized by DAPI.\*\*p \< 0.01, \*\*\*p \< 0.001, \*\*\*\*p \< 0.0001 (paired Student\'s t test). ns, not significant. Error bars represent SD. Also see [Figure S1](#mmc1){ref-type="supplementary-material"}.

A decrease in E-cadherin in epithelial cells during EMT results in a weakening of cell-cell contacts, resulting in an increase in migration rates, which was observed in the PBRM1 knockdown ([Figure 1](#fig1){ref-type="fig"}D) and PBRM1 knockout ([Figure S1](#mmc1){ref-type="supplementary-material"}E). A decrease in E-cadherin also results in a decrease in cellular polarity, a feature central to epithelial function. To investigate the contribution of PBRM1 to the maintenance of epithelial cell polarity we plated NMuMG cells in Matrigel-based 3D culture where they self-assemble into luminal structures consisting of hollow acini displaying apical-basal polarity ([@bib24]). Upon PBRM1 knockdown, the spheres fail to establish hollow lumen and lose both ZO-1 at apical tight junctions and basal or lateral staining of alpha 6 integrin ([Figures 1](#fig1){ref-type="fig"}E and [S1](#mmc1){ref-type="supplementary-material"}F). This phenotype is consistent with that observed in NMuMG epithelial cells with PTEN deletion or PI3K-activating mutation ([@bib2]).

PBRM1 Regulates Genes Involved in Cell Adhesion, Signaling, Stress Response, and Apoptosis {#sec2.2}
------------------------------------------------------------------------------------------

To identify genes regulated by PBRM1 in epithelial cells, we performed RNA sequencing (RNA-seq) from control and PBRM1 knockdown NMuMG cells. In total, we identified 2,467 genes with significantly increased transcript levels and 1,927 genes with significantly decreased transcript levels upon *PBRM1* knockdown ([Table S1](#mmc1){ref-type="supplementary-material"}). Gene ontology (GO) analysis identified numerous pathways significantly enriched in genes downregulated upon shPBRM1, including cell movement, cell structure, development, and signaling ([Figure 2](#fig2){ref-type="fig"}A), as would be expected based on the loss of epithelial characteristics in the PBRM1 knockdown ([Figure 1](#fig1){ref-type="fig"}). In addition, there were numerous enriched biological pathways involved in stress response, cellular homeostasis, translational elongation, and apoptosis. In contrast, there were few significantly enriched biological pathways for genes upregulated upon PBRM1 knockdown; however, these pathways included microtubule-based processes ([Figure 2](#fig2){ref-type="fig"}B).Figure 2PBRM1 Regulates Genes Involved in Cell Adhesion, Signaling, Stress Response, and Apoptosis and Is Predicted to Cooperate with Transcription Factors Involved in Response to Stress(A) Top overrepresented biological process GO terms (p values \< 10^−10^) for differentially expressed genes that are downregulated in NMuMG cells with shPBRM1.(B) Top overrepresented biological process GO terms (p values \< 10^−10^) for differentially expressed genes that are upregulated in NMuMG cells with shPBRM1.(C) Putative transcription factors were identified for genes exhibiting differential expression in NMuMG cells with shPBRM1.(D) Heatmaps of regions identified as differentially accessible with PBRM1 knockdown using ATAC-seq analysis of NMuMG cells. Regions of at least 1.5-fold differential accessibility were calculated between pooled samples of three biological replicates.(E) Metagene plots of the regions identified as differentially accessible with PBRM1 knockdown using ATAC-seq analysis of NMuMG cells.(F) Genomic elements associated with the differentially accessible peaks. The overall distribution was calculated as a percentage of the total differentially accessible regions for each condition.(G) Motif analysis was performed using HOMER for the differentially accessible peaks. Statistically significant motifs were identified based on relative enrichment over genomic areas with similar AT content.(H) The contribution of PBRM1 to the transcriptional regulation of NRF2 (left) or c-Jun (right) target genes using qRT-PCR and *OAZ1* as the housekeeping gene. n = 3. \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001 (paired Student\'s t test). Error bars represent SD.Also see [Figure S2](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc1){ref-type="supplementary-material"}.

PBRM1 Is Predicted to Cooperate with Transcription Factors that Facilitate the Response to Stress {#sec2.3}
-------------------------------------------------------------------------------------------------

We further utilized the RNA-seq datasets to predict upstream regulators that might cooperate with PBRM1 in the transcription of target genes. For genes decreased with shPBRM1, several enriched consensus sequences were identified, with the most robust identified for KLF transcription factors (TFs), including KLF4 ([Figure 2](#fig2){ref-type="fig"}C), which is required for epithelial cell homeostasis ([@bib20], [@bib70]). In fact, the KLF4 knockdown in NMuMG cells has a similar phenotype to the PBRM1 knockdown ([@bib63]). In addition, there was significant enrichment for genes with consensus sequences for ETS TFs, which are primarily thought of as oncogenic, but are involved in a variety of processes like cell cycle, differentiation, and apoptosis ([@bib59]). Last, there was significant enrichment for genes with consensus sequences for AP-1 TFs, such as JUN/FOS and NRF2, which are upregulated during stress ([@bib29], [@bib52]). Similar to the RNA-seq analysis, very few TF consensus sequences were enriched in the promoters of genes upregulated upon shPBRM1, but the main consensus sequences enriched were associated with MBTPS2 ([Figure 2](#fig2){ref-type="fig"}C), a protease that activates TFs involved in cholesterol synthesis and ER stress response ([@bib51]), and YY1, a structural protein involved in promoter-enhancer associations ([@bib1]).

To further define whether these putative TFs are directly regulated by PBRM1\'s chromatin remodeling function, we next turned to Assay for Transposase-Accessible Chromatin (ATAC)-seq to identify sites of PBRM1-dependent chromatin accessibility. As observed elsewhere ([@bib17]), PBRM1 knockdown did not have dramatic effects on global chromatin accessibility. It did, however, result in a significant decrease in accessibility (at least 1.5-fold) at 5,245 sites and increased accessibility at 6,790 in NMuMG cells ([Figures 2](#fig2){ref-type="fig"}D and 2E) with similar genomic distributions ([Figure 2](#fig2){ref-type="fig"}F). Similar results were obtained using PBRM1 knockdown in HK-2 epithelial cells ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B). To identify TFs that are potentially dependent on PBRM1 for chromatin binding, we calculated the enrichment of TF consensus binding sequences at sites with differential accessibility upon PBRM1 knockdown ([Figures 2](#fig2){ref-type="fig"}G and [S2](#mmc1){ref-type="supplementary-material"}C). Several TF consensus sequences were significantly enriched compared with background at sites of increased and decreased accessibility upon shPBRM1. Consensus sequences for KLF, AP-1, ETS, FOXO, and NF-κB TFs were highly enriched in regions with decreased accessibility upon shPBRM1, which correlates with the predicted regulators based on RNA-seq data ([Figure 2](#fig2){ref-type="fig"}C). In addition, there was a significant overlap between genes downregulated upon shPBRM1 and genes with an associated region of decreased accessibility (536 genes, p = 4.5x10^−83^) and these regions displayed enrichment for KLF, AP-1, ETS, and FOXO consensus sequences. Although we observed similar enrichment of consensus sequence-binding sites in the regions with increased accessibility upon shPBRM1, the regions of accessibility did not correlate with genes upregulated upon shPBRM1 (144 genes, p = 0.455). As many of the biological pathways identified were related to apoptosis and stress response, we investigated the cooperation between PBRM1 and c-Jun and NRF2, two TFs that are activated during stress ([@bib29], [@bib52]) ([Figure 2](#fig2){ref-type="fig"}H). Using lentiviral-mediated shRNA knockdown, we found that similar to the PBRM1 knockout, knockdown of c-Jun (but not NRF2) increased proliferation (S2D). Using a publicly available dataset of NRF2 bound and regulated genes in A549 lung cancer cell lines ([GSE113497](ncbi-geo:GSE113497){#intref0010}), we identified 36 NRF2 targets that are also differentially expressed in the PBRM1 knockdown and have associated sites of decreased chromatin accessibility in the shPBRM1 ATAC-seq. Intriguingly, these included canonical NRF2 target antioxidant genes *HMOX1* and *NQO1* ([@bib8]). Using qRT-PCR we confirmed *NRF2* knockdown and evaluated the requirement for PBRM1 on expression of these genes ([Figure 2](#fig2){ref-type="fig"}H, left). In contrast to many published reports, *HMOX1* did not show a dependence on NRF2 for expression, although it was dependent on PBRM1. As expected, *NQO1* was dependent on both NRF2 and PBRM1 for expression. In the absence of comprehensive c-Jun datasets, we selected several putative c-Jun targets from c-Jun N-terminal kinase (JNK)-dependent genes identified in previous studies. These include *BCL2L1*, an anti-apoptotic regulator ([@bib21]); *HK2*, a metabolic enzyme and anti-apoptotic regulator ([@bib28]); and *IL1RL1*, an anti-inflammatory interleukin (IL)-33 receptor ([@bib38]). We confirmed c-Jun knockdown in NMuMG cells using qRT-PCR and validated that these genes are regulated by both PBRM1 and c-Jun ([Figure 2](#fig2){ref-type="fig"}H, right). In summary, genes affected by PBRM1 knockdown are targets of TFs involved in response to stress.

Knockdown of PBRM1 Results in Elevated ROS under Cellular Stress Conditions {#sec2.4}
---------------------------------------------------------------------------

Owing to the transcriptional signature indicating an increased importance for PBRM1 in regulating genes involved in stress response, we next examined how depletion of PBRM1 affects ROS, which are generated by cells under a variety of cellular stresses ([@bib18]). NMuMG cells have low endogenous ROS levels, and PBRM1 knockdown results in a small but significant increase in ROS under normal cell culture conditions ([Figure 3](#fig3){ref-type="fig"}A), as measured by conversion of 2′,7′-dichlorodihydrofluorescein diacetate (H~2~DCFDA) to the highly fluorescent 2′,7′-dichlorofluorescein (DCF) by intracellular ROS. To understand the effects of PBRM1 on ROS under high cellular stress, we looked at ROS levels after recovery from hydrogen peroxide treatment ([Figure 3](#fig3){ref-type="fig"}B), glucose deprivation ([Figure 3](#fig3){ref-type="fig"}C), hypoxia-inducing CoCl~2~ treatment ([Figure 3](#fig3){ref-type="fig"}D), and DNA-damaging doxorubicin treatment ([Figure 3](#fig3){ref-type="fig"}E). Under all these stress conditions, cells lacking PBRM1 expression displayed increased levels of ROS.Figure 3Knockdown of PBRM1 Results in Elevated ROS under Cellular Stress Conditions(A) NMuMG cells were trypsinized and stained for 30 min with H~2~-DCFDA, washed with PBS, and analyzed using flow cytometry. The mean fluorescence value for 10,000 cells was calculated from four independent experiments.(B) NMuMG cells grown in 96-well plates were treated with increasing concentrations of H~2~O~2~ for 1 h, washed with PBS, and incubated with H~2~-DCFDA for 30 min. Reagent was washed away, and the DCF fluorescence was measured in live cells.(C) NMuMG cells grown in 96-well plates were treated with media containing varying concentrations of glucose (normal media = 25 mM) for 16 h, washed with PBS, and incubated with H~2~-DCFDA for 30 min. Reagent was washed away, and the DCF fluorescence was measured in live cells.(D) NMuMG cells grown in 96-well plates were treated with media containing varying concentrations of CoCl~2~ for 24 h, washed with PBS, and incubated with H~2~-DCFDA for 30 min. Reagent was washed away, and the DCF fluorescence was measured in live cells.(E) NMuMG cells grown in 96-well plates were treated with media containing varying concentrations of doxorubicin for 24 h, washed with PBS, and incubated with H~2~-DCFDA for 30 min. Reagent was washed away, and the DCF fluorescence was measured in live cells.\*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001 (paired Student\'s t test). ns, not significant. Error bars represent S.D.

PBRM1 Expression Is Cytoprotective under High-Stress Conditions {#sec2.5}
---------------------------------------------------------------

A low-level increase in ROS production promotes cancer progression by stimulating signaling, and facilitating transformation through increasing genomic instability and inflammation ([Figure 4](#fig4){ref-type="fig"}A) ([@bib18]). In addition, ROS can increase AKT phosphorylation and induce changes in cell adhesion molecules to increase motility ([@bib18]), both of which we observed previously in Caki2 renal cancer cells without PBRM1 ([@bib10]) and in epithelial cells lacking PBRM1 ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Although increases in ROS are characteristic in cancer and contribute to transformation and oncogenesis, cancer cells need to avoid extremely high levels of ROS due to cytotoxicity ([Figure 4](#fig4){ref-type="fig"}A) ([@bib18]). To understand how PBRM1-regulated ROS levels under high-stress conditions affect cellular viability, we measured cell survival after high concentrations of hydrogen peroxide for 16 h. We found that PBRM1 knockdown decreased viability under these high-stress conditions in the NMuMG ([Figure 4](#fig4){ref-type="fig"}B) and MDCK epithelial cells ([Figure S3](#mmc1){ref-type="supplementary-material"}A), an effect observed similarly with the NRF2 knockdown ([Figure S3](#mmc1){ref-type="supplementary-material"}B). This was not due to increased apoptosis in the PBRM1 knockdown, and in fact, cells lacking PBRM1 displayed a deficiency in annexin V ([Figure 4](#fig4){ref-type="fig"}C) and cleaved PARP ([Figures 4](#fig4){ref-type="fig"}D and [S3](#mmc1){ref-type="supplementary-material"}C) under stress conditions. This is in line with the transcriptional role for PBRM1 in regulating pro-apoptotic genes ([Figure 2](#fig2){ref-type="fig"}A). Although it seems counterintuitive that PBRM1-expressing cells have both increased apoptosis and increased cell survival under high-stress conditions, it is consistent with a role for PBRM1 in the stress response, which often results in apoptosis if cellular stresses are not resolved. In contrast, cells lacking PBRM1 are unable to mount a proper response to external stress, leading to high ROS levels and cell death through other means, such as necrosis ([@bib16]), which is supported by the increase in necrosis marker lactate dehydrogenase (LDH) in the NMuMG cells lacking PBRM1 ([Figure 4](#fig4){ref-type="fig"}E).Figure 4PBRM1 Expression Is Cytoprotective under High-Stress ConditionsPBRM1 induces apoptotic pathways and increases cellular viability under high-cellular-stress conditions.(A) Depiction of the multifaceted role ROS regulators play in cancer.(B) NMuMG cells were cultured in normal cell media or 250 μM H~2~O~2~ for 16 h, and the number of live cells were counted using trypan blue.(C) Annexin V staining was measured in NMuMG cells treated with 200 μM H~2~O~2~ for the indicated times. The percentage of annexin V-positive cells was calculated for two independent experiments.(D) Whole-cell lysates were prepared from NMuMG cells treated with 200 μM H~2~O~2~ for the indicated times and probed for the indicated proteins using immunoblot analysis.(E) LDH release was measured from 10 μL media using LDH Cytotoxicity Assay Kit II (Abcam).\*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001, \*\*\*\*p \< 0.0001 (paired Student\'s t test). ns, not significant. Error bars represent SD. Also see [Figure S3](#mmc1){ref-type="supplementary-material"}.

PBRM1-Regulated Transcriptional Effects under Cellular Stress Conditions {#sec2.6}
------------------------------------------------------------------------

To determine if the dependency on PBRM1 expression for viability under stress conditions is due to PBRM1\'s regulation of different genes under stress conditions, we characterized the transcriptional profile of NMuMG cells with and without PBRM1 knockdown, grown in H~2~O~2~ (200 μM) for 2 h or low-glucose media for 6 h. There were between 1,000 and 2,000 differentially expressed genes (DEGs) identified in cells grown in H~2~O~2~ or low-glucose growth conditions for both vector control and shPBRM1 cells ([Table S1](#mmc1){ref-type="supplementary-material"}); however, the impact of PBRM1 knockdown on overall gene expression was more significant than the impact of either stress conditions ([Figure 5](#fig5){ref-type="fig"}A). We observed a significant correlation between gene expression changes induced by PBRM1 knockdown in different stress conditions ([Figure S4](#mmc1){ref-type="supplementary-material"}A), and a significant correlation between gene expression changes induced by stress conditions in the two cell lines (vector and shPBRM1) ([Figure S4](#mmc1){ref-type="supplementary-material"}B) indicating that many genes altered by stress are not dependent on PBRM1 and many genes dependent on PBRM1 are not altered by stress ([Figure S4](#mmc1){ref-type="supplementary-material"}C). In addition, we observed a significant correlation between gene expression changes induced by the two different stress conditions ([Figure S4](#mmc1){ref-type="supplementary-material"}C). As expected, the significantly enriched GO terms were similar for genes regulated by PBRM1 under stress treatment compared with untreated cells; however, more genes from pathways involved in cell adhesion, signaling, and apoptosis were altered upon shPBRM1 under stress treatments ([Figure 5](#fig5){ref-type="fig"}B). Furthermore, we observed several GO terms that were significantly enriched only for genes downregulated with shPBRM1 under either stress treatment, including cell cycle, protein metabolic processes, and cellular response to stress, and for genes downregulated upon shPBRM1 only under H~2~O~2~ treatment, such as RNA processing and DNA damage response ([Figure 5](#fig5){ref-type="fig"}C). Accordingly, there were many genes dependent on PBRM1 expression for induction under H~2~O~2~ stress ([Figure 5](#fig5){ref-type="fig"}D), many of which are involved in cell adhesion, apoptosis, ER stress, and antioxidant response. We used this dataset to identify the NRF2 and c-Jun targets from [Figure 2](#fig2){ref-type="fig"} that were induced under H~2~O~2~ stress. c-Jun target, *IL1RL1*, an IL-33 receptor involved in protection from stress ([@bib38]), requires both PBRM1 and c-Jun for induction upon H~2~O~2~ treatment ([Figure 5](#fig5){ref-type="fig"}E). Similarly, the antioxidant NRF2 targets, *HMOX1* and *NQO1*, are induced upon H~2~O~2~ treatment and require PBRM1 and/or NRF2 for full gene induction ([Figure 5](#fig5){ref-type="fig"}F). In conclusion, the RNA-seq analysis of PBRM1-dependent gene expression under stress conditions supports a role for PBRM1 in inducing a subset of stress response genes to promote cell survival under conditions of high stress.Figure 5PBRM1-Regulated Transcriptional Effects under Cellular Stress Conditions(A) RNA-seq was performed on NMuMG cells grown in 200 μM H~2~O~2~ for 2 h or glucose-free media for 6 h.(B) Top overrepresented biological process GO terms (p \< 10^−10^) for genes differentially expressed upon shPBRM1 in all cell culture conditions.(C) Overrepresented biological process GO terms (p \< 10^−10^) for differentially expressed genes downregulated with shPBRM1 only under H~2~O~2~ or low-glucose cell culture conditions.(D) Representation of the RNA-seq data for a subset of differentially expressed genes that require PBRM1 for upregulation during H~2~O~2~ stress.(E) The contribution of PBRM1 to the transcriptional regulation of c-Jun target gene *IL1RL1* under normal cell culture or 4 h H~2~O~2~ (250 μM) using qRT-PCR and *OAZ1* as the housekeeping gene. n = 3.(F) The contribution of PBRM1 to the transcriptional regulation of NRF2 target genes *NQO1* (left) and *HMOX1* (right) under normal cell culture or 4 h H~2~O~2~ (250 μM) using qRT-PCR and *OAZ1* as the housekeeping gene. n = 3.\*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001 (paired Student\'s t test). ns, not significant. Error bars represent SD. Also see [Figure S4](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc1){ref-type="supplementary-material"}.

PBRM1 Has Cell-Type-Specific Roles in Viability {#sec2.7}
-----------------------------------------------

After establishing that PBRM1 knockdown can have different effects on viability depending on the stress environment, we re-evaluated the premature senescence phenotype previously described for PBRM1 knockout in mouse embryonic fibroblasts (MEFs) ([@bib40]). We confirmed that PBRM1 knockdown ([Figure S5](#mmc1){ref-type="supplementary-material"}A) results in a loss in the proliferative capacity of MEFs ([Figure 6](#fig6){ref-type="fig"}A) similar to published findings with the PBRM1 conditional knockout ([@bib40]). We next observed a significant increase in ROS levels and H~2~O~2~ levels in MEFs upon PBRM1 knockdown ([Figure 6](#fig6){ref-type="fig"}B and [S5](#mmc1){ref-type="supplementary-material"}B), which was most similar to the robust increase in ROS levels observed in shPBRM1 NMuMG cells grown under high-stress conditions. This particular sensitivity of MEFs to PBRM1 knockdown is most likely due to the unique susceptibility of MEFs to oxidative stress from high oxygen content in air ([@bib15]). To support this, we found that exogenous antioxidants such as vitamin C ([Figure 6](#fig6){ref-type="fig"}C) or *N*-acetylcysteine ([Figure S5](#mmc1){ref-type="supplementary-material"}C) were able to reverse the viability defect induced by PBRM1 knockdown in MEFs.Figure 6PBRM1 has Cell-Type-Specific Roles on Viability(A) Mouse embryonic fibroblasts (MEFs) were counted after 72 h growth using trypan blue and data presented as mean ± SD. n = 3.(B) Equal numbers of MEFs were plated in 96-well format. After 24 h the cells were washed with PBS, incubated with H2-DCFDA for 1 h, and the DCF fluorescence was measured in live cells. Data are presented as mean ± SD. n = 5.(C) MEFs were cultured for 8 days in normal media or media supplemented with 20 μg/mL vitamin C. Luminescence was measured using CellTiter-Glo assay system and data presented as mean ± SD. n = 7.(D) Human mammary epithelial cell line MCF10A was counted after 72 h growth using trypan blue to eliminate dead cells (left), and data are presented as mean ± SD. n = 3. MCF10A cells were trypsinized and stained for 30 min with H~2~-DCFDA, washed with PBS, and 100,000 cells were analyzed using flow cytometry (right).(E) Transformed human mammary cell line MCF10A-T1k was counted after 72 h growth using trypan blue to eliminate dead cells (left), and data are presented as mean ± SD. n = 3. MCF10A-T1k cells were trypsinized and stained for 30 min with H~2~-DCFDA, washed with PBS, and 100,000 cells were analyzed using flow cytometry (right).(F) MCF10A-T1k cells were cultured for 7 days in normal media or media supplemented with 20 μg vitamin C (left). Luminescence was measured using CellTiter-Glo assay system (right) and data presented as mean ± SD. n = 3.\*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001, \*\*\*\*p \< 0.0001 (paired Student\'s t test). ns, not significant. Error bars represent SD. Also see [Figures S5](#mmc1){ref-type="supplementary-material"} and [S6](#mmc1){ref-type="supplementary-material"}.

We next sought to examine how intrinsic genetic changes could alter dependency on PBRM1. To do this we employed the MCF10A human mammary epithelial cell line ([@bib60]), and the MCF10A-T1k cell line, which has been transformed with T24-HRas and passaged in a mouse ([@bib12]). We knocked down PBRM1 in both these cell lines ([Figure S6](#mmc1){ref-type="supplementary-material"}A) and found dramatically different effects on viability. Similar to other epithelial cell lines, PBRM1 knockdown in MCF10A results in an increase in proliferation and a slight increase in ROS ([Figure 6](#fig6){ref-type="fig"}D), with some, but not all, of the same changes in gene expression compared with PBRM1 knockdown in NMuMG cells ([Figure S6](#mmc1){ref-type="supplementary-material"}B), In contrast, PBRM1 knockdown in the MCF10A-T1k cell line is highly deleterious to viability, causing cells to cease proliferation altogether within three to four passages ([Figure 6](#fig6){ref-type="fig"}E, left). Similar to MEFs, PBRM1 knockdown in this line induces a highly significant increase in ROS levels ([Figure 6](#fig6){ref-type="fig"}E, right), and similar to MEFs, vitamin C administration can partially restore proliferative capacity in the PBRM1 knockdown ([Figure 6](#fig6){ref-type="fig"}F). The oncogene-induced stress in the MCF10A-T1k cell line promotes dependency on PBRM1 for viability, which may be reflected in its increased level of ROS at baseline compared with MCF10A cells ([Figure S6](#mmc1){ref-type="supplementary-material"}C). In summary, our data up to this point establish that PBRM1 knockdown can have different effects on viability in the same cell line due to different external stress environments, or in two different cell lines due to cell type susceptibilities to stress.

PBRM1 Displays Stress Response Phenotype in Renal Cancer Cells {#sec2.8}
--------------------------------------------------------------

To begin to decipher how the stress response functions observed for PBRM1 in epithelial cells might relate to its role in renal carcinoma, we first determined the enriched GO terms for the genes with decreased expression in patients with PBRM1 mutations, which were similar to the pathways observed in the NMuMG cells, including cell adhesion, neuronal processes, apoptosis, and ER stress or proteolysis ([Figure S7](#mmc1){ref-type="supplementary-material"}A). Furthermore, we compared the differentially regulated genes and observed the most significant gene overlap between genes with decreased expression in patients with PBRM1 mutations and genes with decreased expression in the PBRM1 knockdown ([S7](#mmc1){ref-type="supplementary-material"}B), similar to the overlaps we observed with Caki2 cells, a renal carcinoma cell line with loss-of-function mutations in PBRM1 ([@bib10]). Therefore we used Caki2 ccRCC cell lines with PBRM1 re-expression to determine if the same phenotypes are observed in the renal cancer setting. Previously we have shown that re-expression of PBRM1 decreases growth and migration of Caki2 cells ([@bib10]). When we used DCF staining to determine ROS levels, we observed highly elevated ROS compared with the epithelial cells, which is consistent with previous observations about high ROS in cancer cell lines ([@bib18]) ([Figures 3](#fig3){ref-type="fig"}A and [7](#fig7){ref-type="fig"}A). However, the re-expression of PBRM1 only reduced ROS levels to a very slight degree under normal cell culture conditions ([Figure 7](#fig7){ref-type="fig"}A). In contrast to the NMuMG cells, high-stress conditions in Caki2 cells did not result in an increase in ROS levels in the absence of PBRM1; however, in the presence of PBRM1, high-stress conditions induced a dramatic decrease in ROS levels ([Figures 7](#fig7){ref-type="fig"}B and 7C). Furthermore, PBRM1 re-expression promoted cell survival under high-stress conditions ([Figure 7](#fig7){ref-type="fig"}D), similar to the phenotype observed in NMuMG cells ([Figure 4](#fig4){ref-type="fig"}B). Also similar to the phenotype observed in NMuMG cells, Caki2 cells with PBRM1 re-expression display a greater increase in cleaved PARP, an apoptosis marker, under hydrogen peroxide treatment conditions ([Figure 7](#fig7){ref-type="fig"}E). Activation of apoptosis seems conflicting with PBRM1\'s role in survival, whereas it is consistent with a role for PBRM1 in activating stress response pathways that eventually lead to apoptosis under continued cellular stress ([@bib16]). In contrast, Caki2 cells lacking PBRM1 display an increase in LDH when exposed to H~2~O~2~ stress, indicative of eventual necrosis from failing to properly activate stress response pathways ([Figure 7](#fig7){ref-type="fig"}F).Figure 7PBRM1 Displays Stress Response Phenotype in Renal Cancer CellsPBRM1 regulates stress response in renal carcinoma cells.(A) Caki2 cells were trypsinized and stained for 30 min with H~2~-DCFDA, washed with PBS, and analyzed using flow cytometry. The mean fluorescence value for 10,000 cells was calculated from seven independent experiments.(B) Caki2 cells grown in 96-well plates were treated with increasing concentrations of H~2~O~2~ for 1 h, washed with PBS, and incubated with H~2~-DCFDA for 30 min. Reagent was washed away, and the DCF fluorescence was measured in live cells.(C) Caki2 cells grown in 96-well plates were treated with glucose-free media for varying time periods, washed with PBS, and incubated with H~2~-DCFDA for 30 min. Reagent was washed away, and the DCF fluorescence was measured in live cells.(D) Caki2 cells were cultured in normal cell media or 200 μM H~2~O~2~ for 16 h, and the cell viability was estimated using crystal violet staining.(E) Whole-cell lysates were prepared from Caki2 cells treated with 200 μM H~2~O~2~ or 100 μM camptothecin for 2 h, and relative levels of indicated proteins were probed using immunoblot analysis. Irrelevant lane was spliced out.(F) LDH release was measured from 10 μL media using LDH Cytotoxicity Assay Kit II (Abcam).\*p \< 0.05, \*\*\*p \< 0.001, \*\*\*\*p \< 0.0001 (paired Student\'s t test). ns, not significant. Error bars represent SD. Also see [Figure S7](#mmc1){ref-type="supplementary-material"}.

Discussion {#sec3}
==========

Chromatin regulators are frequently misregulated in cancer with resulting alterations in gene transcription; however, many of these regulators alter a large number of genes to a small degree and can regulate very different sets of genes in different cell lines. An additional challenge resides in the fact that many chromatin regulators modulate transcription differently depending on environmental inputs ([@bib30]). Thus it has been incredibly challenging to decipher how the transcriptional effects of chromatin regulators observed in a particular cell line relate to its general biochemical function or its phenotype *in vivo*. Traditional cell culture models are often devoid of the environmental stimuli chromatin regulators normally sense, making it a significant challenge to develop a relevant cell culture model for accurately studying these regulators. Here, we have used transcriptional analysis of epithelial cells with PBRM1 knockdown to identify pathways involved in epithelial cell maintenance and stress response. In addition, we have validated a role for PBRM1 in the maintenance of epithelial cell identity and identified KLF, AP-1, and ETS TFs consensus sequences in both genes downregulated upon shPBRM1 and regions with decreased chromatin accessibility upon shPBRM1. From this, we have validated a role for PBRM1 in facilitating the transcription of c-Jun and NRF2 target genes, restraining ROS production and inducing both apoptotic and cell survival pathways under high-stress conditions ([@bib53], [@bib67]).

In addition to changes in TF expression and localization during cellular stress, oxidative stress and metabolic stress are known to specifically upregulate H3K14Ac at stress response genes ([@bib55]), a histone mark specifically recognized by PBRM1 ([@bib50]). H3K14Ac is generally found at active promoters with H3K9Ac, whereas it is found without H3K9Ac at inducible genes ([@bib36]) and is specifically increased in gene bodies during stress ([@bib31]). H3K14Ac is also a mark associated with renal epithelium adaptation to oxidative stress ([@bib42], [@bib41]), high-fat-diet-induced inflammation in rodents ([@bib61]), ER stress ([@bib13]), and sites of DNA damage ([@bib7]), a process for which PBRM1 has a well-established role ([@bib34]). Therefore specific patterns of histone acetylation likely delineate a subset of stress response genes targeted by PBRM1, which is likely to be unique for a particular cell type, as well as a particular stressor.

A role for PBRM1 in stress response is in agreement with recent findings that PBRM1 deletion alone is not sufficient for transformation but acts to facilitate oncogenesis in cooperation with VHL deletion ([@bib15], [@bib23], [@bib46]). PBRM1 deletion allows for an amplification of oncogenic signaling ([@bib17], [@bib46]), as well as a bypass of checkpoints induced by replication stress after VHL deletion ([@bib15]). This could be in part due to PBRM1\'s role in regulating the hypoxic stress response in cooperation with HIF1a, which allows for the reduction of ROS and induction of apoptosis in response to hypoxia ([@bib37]).

A role in stress response is likely part of PBRM1\'s function as a tumor suppressor during cancer initiation, and it may also be involved in PBRM1\'s protective function against cancer therapeutics, similar to the protective role PBRM1 plays under high-stress conditions. Patients with ccRCC with PBRM1 mutations tend to have favorable prognosis ([@bib49]), and recent studies indicate that PBRM1 mutant tumors respond particularly well to sunitinib ([@bib3]) and PD-1 inhibitors ([@bib43]). In support of this, a recent CRISPR-Cas9 screen identified PBRM1, along with other PBAF-specific subunits, as resistance factors against T cell-mediated killing ([@bib47]). This is related to a general role for PBRM1 in suppressing the inflammatory response, as PBRM1 deletion also increases innate immunity hyperinflammation in the gut ([@bib25], [@bib58]). The general role for PBRM1 in stress response could relate to PBRM1\'s role in suppressing inflammation (and T cell-mediated toxicity) through the regulation of homeostasis ([@bib9]), although that connection will need to be explored further.

Limitations of Study {#sec3.1}
--------------------

Using epithelial cell lines, we have defined a role for PBRM1 in mediating the expression of stress response genes. Although this finding unifies the disparate results previously published regarding PBRM1\'s cellular function and provides a framework for future studies, it does not provide a precise mechanism for PBRM1\'s function. In addition, although we observe similar functions for PBRM1 in a renal cancer cell line, our work does not make any conclusions about whether PBRM1\'s role in the transcription of stress response genes is its primary function as a tumor suppressor during renal carcinoma progression. Lastly, although a transcriptional role in stress response is typical for chromatin regulators involved in DNA damage repair ([@bib22]), we have not defined here whether the observed role for PBRM1 in upregulating stress response genes is truly independent from its role in DNA damage repair. Additional mechanistic work will be required to dissect these functions on a molecular level.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Data and Software Availability {#appsec1}
==============================

Data sets generated in these experiments are available at the Gene Expression Omnibus under accession number GSE113606.
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Document S1. Transparent Methods and Figures S1--S7Table S1. RNA-Seq of NMuMG Cells, Related to Figures 2 and 5RNA was isolated from NMuMG cells with empty lentiviral vector or shPBRM1 lentiviral vector. Cells were treated with normal media, H~2~O~2~ (200 μM) for 2 h, or glucose-free media for 6 h. The summary of results, the quality control, and the EdgeR output for each condition are depicted in separate tabs.
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